Case Report: Application of ex-vivo drug sensitivity testing to identify personalized treatment options for an adolescent with diffuse midline glioma.
Saved in:
| Title: | Case Report: Application of ex-vivo drug sensitivity testing to identify personalized treatment options for an adolescent with diffuse midline glioma. |
|---|---|
| Authors: | Tan PK; The Cure Starts Now Foundation, Cincinnati, OH, United States.; Yuvaan Tiwari Foundation, Atlanta, GA, United States., Martins TJ; Institute for Stem Cell and Regenerative Medicine, University of Washington School of Medicine, Seattle, WA, United States., Becker PS; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA, United States.; Department of Hematologic Malignancies Translational Science, City of Hope National Medical Center, Duarte, WA, United States.; Department of Medicine, University of Washington, Seattle, WA, United States., Wechsler-Reya RJ; Cancer Genome and Epigenetics Program, National Cancer Institute (NCI)-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, United States.; Department of Neurology and Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY, United States., Crawford JR; Rady Children's Hospital, San Diego, CA, United States.; Children's Hospital of Orange County, Orange, CA, United States.; Department of Pediatrics and Neurology, University of California Irvine, Irvine, CA, United States. |
| Source: | Frontiers in oncology [Front Oncol] 2025 Aug 07; Vol. 15, pp. 1606575. Date of Electronic Publication: 2025 Aug 07 (Print Publication: 2025). |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
